chronic hemolytic anemia and variable jaundice present since birth and progressive neurologic disease considered secondary to kernicterus. Both parents had been born in Louisiana of French-Negro ...
The FDA granted orphan designation to Sanofi ( SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on TheFly – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback